T cell decision-making decodes the dynamic antigenic landscape
-
By
-
Inbal Eizenberg-Magar
-
Lior Dayan
-
Benny Chain
-
Yaron E. Antebi
-
June 1, 2026
-
Clinical Scorecard: T Cell Decision Processes Interpret the Evolving Antigenic Environment
At a Glance
| Category | Detail |
|---|
| Condition | T cell activation and fate in response to dynamic antigenic environments |
| Key Mechanisms | Kinetic proofreading of TCR signaling, frequency-dependent decoding, population-level feedback circuits |
| Target Population | Individuals with varying T cell populations including naïve, effector, and memory T cells |
| Care Setting | Research and clinical settings focusing on immunology and vaccine development |
Key Highlights
- Antigen levels fluctuate dramatically across temporal and spatial scales.
- T cells respond to both antigen quantity and rate of change.
- Manipulating antigen exposure dynamics can modulate immune responses.
- T cell responses vary based on TCR affinity and microenvironmental cues.
- Chronic low-dose exposure can lead to different immune outcomes compared to acute exposure.
Guideline-Based Recommendations
Diagnosis
- Consider the dynamic nature of antigen exposure in immunological assessments.
Management
- Incorporate temporal features into immunological models for better therapeutic strategies.
Monitoring & Follow-up
- Monitor antigen concentration and exposure dynamics in patients.
Risks
- Slow antigen exposure may facilitate immune evasion in cancer.
Patient & Prescribing Data
Patients exposed to various antigens including pathogens, tumors, and environmental agents.
Controlled vaccine delivery can be used to manipulate immune responses.
Clinical Best Practices
- Evaluate T cell responses considering both antigen dynamics and individual T cell characteristics.
- Utilize population-level feedback circuits in therapeutic strategies.
Related Resources & Content
